Tech Company Financing Transactions
Abreos Biosciences Funding Round
Abreos Biosciences closed a $1.1 million funding round on 6/6/2017. Investors included private investors.
Transaction Overview
Company Name
Announced On
6/6/2017
Transaction Type
Debt
Amount
$1,050,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 10 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2223 Avenida de la Playa 206
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Abreos Biosciences is an early stage biotech company pioneering assays for detection of biologic drugs using its proprietary Veritope technology. Abreos develops laboratory-based and point-of-care assays that enable personalized dosing and counterfeit detection of these expensive drugs, such as therapeutic monoclonal antibodies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bradley Messmer
Chief Operating Officer
Michael Little
Browse more venture capital transactions:
Prev: 6/6/2017: Benefit Mobile venture capital transaction
Next: 6/6/2017: Emocha Mobile Health venture capital transaction
Share this article
News on VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs